TAK-593 25mg

TAK-593 is an oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity.

Price Not Available 25mg TAK-593 25mg Supplier Page

Trivial name	TAK-593 25mg
Catalog Number	A13555-25
Alternative Name(s)	N-(5-((2-(cyclopropanecarboxamido)imidazo[1,2-b]pyridazin-6-yl)oxy)-2-methylphenyl)-1,3-dimethyl-1H-pyrazole-5-carboxamide
Molecular Formula	C23H23N7O3
CAS#	1005780-62-0
SMILES	CC1=C(C=C(C=C1)OC2=NN3C=C(N=C3C=C2)NC(=O)C4CC4)NC(=O)C5=CC(=NN5C)C
Size	25mg
Supplier Page	http://www.adooq.com/tak-593.html